Metabolic disturbances and obesity are major cardiovascular risk factors in patients with
schizophrenia, resulting in a higher mortality rate and shorter life expectancy compared with …

The high prevalence of metabolic syndrome in persons with schizophrenia has spurred
investigational efforts to study the mechanism beneath its pathophysiology. Early psychosis …

Opinion Statement Olanzapine has become a major drug in the management of
chemotherapy-induced nausea and vomiting as a prophylactic agent. In addition, a recent …

The metabolic syndrome (MetS) affects individuals with schizophrenia at a higher rate when
compared to individuals in the general population. Accumulating evidence indicated that …

Background Psychiatric disorders differ in their prevalence, symptom profiles, and disease
courses in men and women. However, sex differences in psychiatric disorders have not …

Antipsychotic-induced metabolic disturbance is a common adverse event occurring in
patients treated with antipsychotic drugs. The mechanisms underlying metabolic …

Metabolic syndrome (MetS) is a common complication of schizophrenia that is quite
exacerbated by long-term use of (atypical) antipsychotics. The mechanism of MetS has …

Clozapine-induced constipation is a frequently overlooked side effect that can prove fatal.
This study aimed to investigate the prevalence of constipation and the breakdown of …

The objective of the study was to investigate the regulatory actions of unacylated ghrelin
(UAG) on glucose-sensitive (GS) neurons and glycolipid metabolism in the lateral …

ABSTRACT Oğuz, Osman.(2021). Investigation of The Relationship Between “GHRL
(rs4684677)”,“FTO (rs8044769)” and “PGC-1α (rs8192678)”“Polymorphisms” In Diabetic …